M. Kamouchi

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
M Kamouchi, M. Kamouchi, Masahiro Kamouchi
Publication record
239 papers · 5,946 citations · H-index 43

PAPERS

RNF213 p.R4810K Variant and Intracranial Atherosclerosis: Increased Risk in Obese Variant Carriers
20260 citationsauthor #12
Clinical Outcomes following Acute Ischaemic Stroke in Patients with Comorbid Cancer
20250 citationsauthor #11
Abstract TP267: Effects of Exposure to Chemical Components of Fine Particulate Matter on Ischemic Stroke: A Case-Crossover Study
20250 citationsauthor #7
Comparative analysis of prognostic scores for functional outcome after ischemic stroke.
20250 citationsauthor #7
Association between Ambient Temperature and Risk of Ischaemic Stroke: An Observational Cohort Study.
20250 citationsauthor #6
Association between procedure volume and 30-day mortality in stroke patients treated with EVT or IV rt-PA during the introduction period of EVT in Japan.
20250 citationsauthor #7
Impact of lean body mass index on short-term outcomes in patients with ischemic stroke: an observational cohort study
20250 citationsauthor #24
Author's Reply to "Socioeconomic and Technological Considerations in Stroke Prognosis: A Comment on Irie et al." by Saboor et al.
20250 citationsauthor #3
Functional Outcome Prediction in Japanese Patients with Nonsurgical Intracerebral Hemorrhage: The FSR ICH Score
20251 citationsauthor #8
Exploring the relationship of platelet aggregation function with efficacy and safety outcomes following the administration of prasugrel and clopidogrel in patients with thrombotic stroke: a post hoc analysis of PRASTRO pooled studies
20250 citationsauthor #2
Impact of lean body mass index on short-term outcomes in patients with ischemic stroke: an observational cohort study
20250 citationsauthor #8
Factors related to sex differences in long-term functional decline after acute ischemic stroke
20252 citationsauthor #7
Performance of multimodal prediction models for intracerebral hemorrhage outcomes using real-world data
20252 citationsauthor #10
Effect of smoking status on clinical outcomes after reperfusion therapy for acute ischemic stroke
20242 citationsauthor #5
Association between abdominal adiposity and clinical outcomes in patients with acute ischemic stroke
20241 citationsauthor #6
Association between pulse pressure and risk of acute kidney injury after intracerebral hemorrhage
20243 citationsauthor #8
Machine Learning–Based Prediction for In‐Hospital Mortality After Acute Intracerebral Hemorrhage Using Real‐World Clinical and Image Data
20247 citationsauthor #8
Association between pulse pressure and risk of acute kidney injury after intracerebral hemorrhage
20243 citationsauthor #24
Body temperature in the acute phase and clinical outcomes after acute ischemic stroke
20244 citationsauthor #9
Antiplatelets for Cardiovascular Disease in Non-valvular AF with Rivaroxaban: A Subanalysis of the EXPAND Study
20240 citationsauthor #9
Effect of smoking status on clinical outcomes after reperfusion therapy for acute ischemic stroke
20242 citationsauthor #22
Data‐driven prediction of prolonged air leak after video‐assisted thoracoscopic surgery for lung cancer: Development and validation of machine‐learning‐based models using real‐world data through the ePath system
20242 citationsauthor #16
Sex Differences in Long-Term Functional Decline after Ischemic Stroke: A Longitudinal Observational Study from the Fukuoka Stroke Registry
20235 citationsauthor #7
Temporal Generalizability of Machine Learning Models for Predicting Postoperative Delirium Using Electronic Health Record Data: Model Development and Validation Study
202310 citationsauthor #8
Effectiveness and safety of reduced-dose rivaroxaban for elderly patients with non-valvular atrial fibrillation: A subanalysis of the EXPAND study.
20231 citationsauthor #8
Modification of the effects of age on clinical outcomes through management of lifestyle-related factors in patients with acute ischemic stroke.
202312 citationsauthor #7
Predictive Performance of Machine Learning–Based Models for Poststroke Clinical Outcomes in Comparison With Conventional Prognostic Scores: Multicenter, Hospital-Based Observational Study
20234 citationsauthor #9
Comparison of Prasugrel and Clopidogrel in Thrombotic Stroke Patients with Risk Factors for Ischemic Stroke Recurrence: An Integrated Analysis of PRASTRO-I, PRASTRO-II, and PRASTRO-III
20238 citationsauthor #2
Association between decreases in serum uric acid levels and unfavorable outcomes after ischemic stroke: A multicenter hospital-based observational study
20238 citationsauthor #8
Decreased Estimated Glomerular Filtration Rate and Proteinuria and Long-Term Outcomes After Ischemic Stroke: A Longitudinal Observational Cohort Study
20235 citationsauthor #7
Non-linear association between body weight and functional outcome after acute ischemic stroke
202312 citationsauthor #9
Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries
2022130 citationsauthor #72
Hyporesponsiveness to erythropoiesis-stimulating agent in non-dialysis-dependent CKD patients: The BRIGHTEN study
202218 citationsauthor #14
Causes of ischemic stroke in young adults versus non-young adults: A multicenter hospital-based observational study
202240 citationsauthor #8
Efficacy and Safety of Prasugrel vs Clopidogrel in Thrombotic Stroke Patients With Risk Factors for Ischemic Stroke Recurrence: A Double-blind, Phase III Study (PRASTRO-III)
202220 citationsauthor #2
Heart Failure　- Under-Recognized Link to Post-Stroke Functional Status.
20222 citationsauthor #1
Sex Differences in the Risk of 30-Day Death After Acute Ischemic Stroke
20215 citationsauthor #6
Regional Disparity of Reperfusion Therapy for Acute Ischemic Stroke in Japan: A Retrospective Analysis of Nationwide Claims Data from 2010 to 2015
202120 citationsauthor #6
Pre-Stroke Cholinesterase Inhibitor Treatment Is Beneficially Associated with Functional Outcome in Patients with Acute Ischemic Stroke and Pre-Stroke Dementia: The Fukuoka Stroke Registry
20215 citationsauthor #5
β-Cell Function and Clinical Outcome in Nondiabetic Patients With Acute Ischemic Stroke
20215 citationsauthor #6
Nationwide temporal trend analysis of reperfusion therapy utilization and mortality in acute ischemic stroke patients in Japan
20215 citationsauthor #7
Day-by-Day Blood Pressure Variability in the Subacute Stage of Ischemic Stroke and Long-Term Recurrence
202112 citationsauthor #3
Ischemic stroke, hemorrhage, and mortality in patients with non-valvular atrial fibrillation and renal dysfunction treated with rivaroxaban: sub-analysis of the EXPAND study
202113 citationsauthor #8
Initial responsiveness to darbepoetin alfa and its contributing factors in non-dialysis chronic kidney disease patients in Japan
202011 citationsauthor #13
Impact of a learning health system on acute care and medical complications after intracerebral hemorrhage
20207 citationsauthor #15
Effect of treatment modality and cerebral vasospasm agent on patient outcomes after aneurysmal subarachnoid hemorrhage in the elderly aged 75 years and older
202020 citationsauthor #17
Anticoagulation and Risk of Stroke Recurrence in Patients with Embolic Stroke of Undetermined Source Having No Potential Source of Embolism
20204 citationsauthor #8
Stroke Prognostic Scores and Data-Driven Prediction of Clinical Outcomes After Acute Ischemic Stroke
202062 citationsauthor #6
Publisher Correction: Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes
20198 citationsauthor #206
Poor glycemic control and posterior circulation ischemic stroke
201911 citationsauthor #5
Clinical risk factors of stroke and major bleeding in patients with non-valvular atrial fibrillation under rivaroxaban: the EXPAND Study sub-analysis
201925 citationsauthor #9
Lessons from the Trials for the Desirable Effects of Sodium Glucose Co-Transporter 2 Inhibitors on Diabetic Cardiovascular Events and Renal Dysfunction
201919 citationsauthor #2
Correction to: Clinical risk factors of stroke and major bleeding in patients with non-valvular atrial fibrillation under rivaroxaban: the EXPAND Study sub-analysis
20192 citationsauthor #9
Global Outcome Assessment Life-long after stroke in young adults initiative—the GOAL initiative: study protocol and rationale of a multicentre retrospective individual patient data meta-analysis
201916 citationsauthor #27
Personalized antiplatelet and anticoagulation therapy: Pharmacogenomics
20190 citationsauthor #2
Association of Embolic Sources With Cause-Specific Functional Outcomes Among Adults With Cryptogenic Stroke
201829 citationsauthor #4
Safety of antithrombotic therapy for patients with acute ischemic stroke harboring unruptured intracranial aneurysm
201813 citationsauthor #8
Insulin resistance and clinical outcomes after acute ischemic stroke
201894 citationsauthor #7
Abstract TP75: Prognosis in Mild or Rapidly Improving Ischemic Stroke Not Treated With Recombinant Tissue Plasminogen Activator: Fukuoka Stroke Registry
20180 citationsauthor #8
Stroke in the Elderly Population
20181 citationsauthor #1
The EXPAND study: Efficacy and safety of rivaroxaban in Japanese patients with non-valvular atrial fibrillation.
201847 citationsauthor #7
Erratum to: Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial)
20180 citationsauthor #12
Primary and secondary prevention of stroke and systemic embolism with rivaroxaban in patients with non-valvular atrial fibrillation
20183 citationsauthor #8
Association between the maximal distance of atrial septal protrusion and cryptogenic stroke
20177 citationsauthor #8
Timing of Anticoagulant Therapy After Acute Ischemic Stroke.
20170 citationsauthor #2
Primary and secondary prevention of stroke and systemic embolism with rivaroxaban in patients with non-valvular atrial fibrillation (sub-analysis of the expand study)
20174 citationsauthor #8
Optimal Anticoagulation for Patients With Atrial Fibrillation　- Benefits for Reducing Stroke Severity.
20170 citationsauthor #1
Abstract TP253: A Novel Prehospital Scale to Predict Candidates for Acute Stroke Thrombectomy : The Fukuoka Acute Stroke ThrombEctomy pRediction (FASTER) Scale
20170 citationsauthor #5
Left Atrial Size and Long‐Term Risk of Recurrent Stroke After Acute Ischemic Stroke in Patients With Nonvalvular Atrial Fibrillation
201743 citationsauthor #8
Association Between Onset-to-Door Time and Clinical Outcomes After Ischemic Stroke
201753 citationsauthor #11
Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial)
201718 citationsauthor #12
Plasma C-Reactive Protein and Clinical Outcomes after Acute Ischemic Stroke: A Prospective Observational Study
201659 citationsauthor #8
Contents Vol. 42, 2016
20160 citationsauthor #189
Study Design and Baseline Characteristics of the EXPAND Study: Evaluation of Effectiveness and Safety of Xa Inhibitor, Rivaroxaban for the Prevention of Stroke and Systemic Embolism in a Nationwide Cohort of Japanese Patients Diagnosed as Non-Valvular Atrial Fibrillation.
201611 citationsauthor #8
Adverse Influence of Pre-Stroke Dementia on Short-Term Functional Outcomes in Patients with Acute Ischemic Stroke: The Fukuoka Stroke Registry
201620 citationsauthor #6
Abstract TP207: Pre-stroke Dementia is Associated With Poor Functional Outcome After Acute Ischemic Stroke: The Fukuoka Stroke Registry
20160 citationsauthor #6
Ischemic stroke in patients with chronic kidney disease
20160 citationsauthor #1
Impaired Swallowing in Hospitalized Patients: An Observational Study in a Community Hospital in Japan (2012–2014)
201613 citationsauthor #8
Short-Term Exposure to Fine Particulate Matter and Risk of Ischemic Stroke
201635 citationsauthor #7
Research for biomarkers in ischemic stroke (REBIOS)
20161 citationsauthor #3
Possible involvement of basic FGF in the upregulation of PDGFRβ in pericytes after ischemic stroke.
201660 citationsauthor #9
Causes of Ischemic Stroke in Patients with Non-Valvular Atrial Fibrillation
201617 citationsauthor #11
Supplementary Material for: Adverse Influence of Pre-Stroke Dementia on Short-Term Functional Outcomes in Patients with Acute Ischemic Stroke: The Fukuoka Stroke Registry
20160 citationsauthor #6
An association between fine particulate matter (PM2.5) levels and emergency ambulance dispatches for cardiovascular diseases in Japan
201614 citationsauthor #3
Influence of Statin Pretreatment on Initial Neurological Severity and Short-Term Functional Outcome in Acute Ischemic Stroke Patients: The Fukuoka Stroke Registry
201615 citationsauthor #10
Influence of Statin Pretreatment on Initial Neurological Severity and Short-Term Functional Outcome in Acute Ischemic Stroke Patients: The Fukuoka Stroke Registry.
201619 citationsauthor #10
Sex Differences in Short-Term Outcomes After Acute Ischemic Stroke: The Fukuoka Stroke Registry
201556 citationsauthor #2
Involvement of platelet-derived growth factor receptor β in fibrosis through extracellular matrix protein production after ischemic stroke.
201588 citationsauthor #11
Effects of hydrochlorothiazide on oxidative stress and pulse pressure in hypertensive patients with chronic stroke: the EMINENT study.
20154 citationsauthor #2
Day-by-Day Blood Pressure Variability and Functional Outcome After Acute Ischemic Stroke: Fukuoka Stroke Registry
201574 citationsauthor #3
A CADASIL-Like Case with a Novel Noncysteine Mutation of the NOTCH3 Gene and Granular Deposits in the Renal Arterioles
20155 citationsauthor #9
Cerebral Small-Vessel Disease in Neuro-Behçet Disease.
20156 citationsauthor #4
Aortic Dissection as a Possible Underlying Cause of Acute Ischemic Stroke.
20158 citationsauthor #1
Contents Vol. 51, 2014
20150 citationsauthor #28
Trends in the Incidence and Survival of Intracerebral Hemorrhage by its Location in a Japanese Community – The Hisayama Study –
20143 citationsauthor #10
The Development of Educational Tool to Support Disease Management Nurses for Preventing the Recurrence of Brain Infarction
20140 citationsauthor #4
Abstract T P157: The Impact of Estimated Glomerular Filtration Rate on a Recurrence of Ischemic Stroke: The Fukuoka Stroke Registry
20140 citationsauthor #2
ABCD3 and ABCD3-I Scores Are Superior to ABCD2 Score in the Prediction of Short- and Long-Term Risks of Stroke After Transient Ischemic Attack
201498 citationsauthor #2
Nox4 Is a Major Source of Superoxide Production in Human Brain Pericytes
201472 citationsauthor #7
Gastrointestinal Bleeding in Acute Ischemic Stroke: Recent Trends from the Fukuoka Stroke Registry
201454 citationsauthor #2

TIMELINE

1987 1 citations

1991 69 citations

1992 1 citations

1993 15 citations

1994 58 citations

1995 6 citations

1996 2 citations

1997 246 citations

1998 21 citations

1999 295 citations

2000 23 citations

2001 7 citations

2002 97 citations

2003 157 citations

2004 301 citations

2005 582 citations

2006 43 citations

2007 101 citations

2008 179 citations

2009 91 citations

2010 21 citations

2011 399 citations

2012 751 citations

2013 601 citations

2014 511 citations

2015 241 citations

2016 264 citations

2017 125 citations

2018 187 citations

2019 81 citations

2020 104 citations

2021 65 citations

2022 210 citations

2023 65 citations

2024 19 citations

2025 5 citations

2026 0 citations

Unknown 3 citations

M. Kamouchi

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT